Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

AB Glymprd M2 Tablet

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview AB Glymprd M2 Tablet

Glymduo MR 2mg/500mg tablets are classified as antidiabetic medications, a dual-action formulation for managing type 2 diabetes in adults. This medication helps regulate blood glucose. Glymduo MR 2mg/500mg tablets should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision could lead to elevated blood sugar, increasing the risk of complications such as renal impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremor. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of AB Glymprd M2 Tablet

Managing type 2 diabetes

Major Benefits of AB Glymprd M2 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The AB Glymprd M 2mg/500mg Tablet should be administered with a meal.

Common Side effects of AB Glymprd M2 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use AB Glymprd M2 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the AB Glymprd M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How AB Glymprd M2 Tablet works:

Each AB Glymprd M 2mg/500mg tablet unites glimepiride (2mg) and metformin (500mg), two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking AB Glymprd M 2mg/500mg tablets is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of AB Glymprd M 2mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks before recommending its use. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid AB Glymprd M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use AB Glymprd M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. The use of AB Glymprd M 2mg/500mg tablets is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use AB Glymprd M 2mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in cases of severe liver disease.

What if you forget to take AB Glymprd M2 Tablet :

Should you forget to take your AB Glymprd M 2mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About AB Glymprd M2 Tablet

LabelValue
Addictive None.
Medication Category Diabetes medication

FAQs on AB Glymprd M2 Tablet

Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure that it remains inaccessible to children, animals, and others.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential adverse effect of AB Glymprd M 2mg/500mg Tablet. This complication, also termed MALA (Metformin-associated lactic acidosis), though infrequent, poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate cessation of AB Glymprd M 2mg/500mg Tablet use and prompt medical attention.
The AB Glymprd M 2mg/500mg tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
AB Glymprd M 2mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse events such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of AB Glymprd M 2mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate this risk, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, AB Glymprd M 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Low blood sugar can manifest as nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This side effect is more probable if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are concurrently used. Therefore, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol concurrently with AB Glymprd M 2mg/500mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
AB Glymprd M2 Tablet
264